Articles

Business, Review Article

Persistent GERD Symptoms Call for Change in Care Management Coverage: A Real-World Perspective for Chronic Care Policy

F. Randy Vogenberg, PhD, FASHP, and Murray L. Harber

Business, Original Research

Reducing the Price of Total Hip Arthroplasty Implant Costs Through Reference Pricing: An Economic Evaluation

Christopher J. Fang, MD; Jonathan M. Shaker, MS; Daniel M. Ward, MD; Carl T. Talmo, MD; Andrew Jawa, MD; David A. Mattingly, MD; Eric L. Smith, MD

Business, Original Research

Cost-Effectiveness of de novo Simvastatin as Adjunctive Therapy in Patients Critically Ill with Sepsis

Sara Mostafa Eladawy, MSc, PhD; Mohamed Abd Alsalam Elgendy, MD; Mamdouh Ahmed Zaki, MD; Naglaa Samir Bazan, MSc, PhD

FDA Oncology Update

Rezlidhia New IDH1 Inhibitor FDA Approved for Relapsed or Refractory AML with IDH1 Mutation

FDA Oncology Update

Elahere, First FRα-Directed Antibody, FDA Approved for FRα-Positive, Platinum-Resistant Ovarian Cancer

FDA Oncology Update

Tecvayli, First Bispecific BCMA-Directed CD3 T-Cell Engager, Received FDA Approval for Relapsed or Refractory Multiple Myeloma

FDA Oncology Update

Imjudo, a New CTLA-4 Inhibitor FDA Approved in Combination with Imfinzi for Unresectable Hepatocellular Carcinoma

FDA Oncology Update

Imjudo FDA Approved with Imfinzi and Chemotherapy for Metastatic Non–Small-Cell Lung Cancer

Adjunctive Lipid-Lowering Strategies for Patients Needing Additional LDL-C Lowering

Nubeqa Now Indicated for Metastatic Hormone-Sensitive Prostate Cancer

1
2
3
4

Page 1 of 240
Results 1 - 10 of 2392

SUBSCRIBE

Copyright © Amplity Medical Communications. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.